232 related articles for article (PubMed ID: 23299436)
1. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
[TBL] [Abstract][Full Text] [Related]
2. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
6. Molecular detection of peripheral blood breast cancer mRNA transcripts as a surrogate biomarker for circulating tumor cells.
Lasa A; Garcia A; Alonso C; Millet P; Cornet M; Ramón y Cajal T; Baiget M; Barnadas A
PLoS One; 2013; 8(9):e74079. PubMed ID: 24058517
[TBL] [Abstract][Full Text] [Related]
7. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.
Reinholz MM; Kitzmann KA; Tenner K; Hillman D; Dueck AC; Hobday TJ; Northfelt DW; Moreno-Aspitia A; Roy V; LaPlant B; Allred JB; Stella PJ; Lingle WL; Perez EA
Clin Cancer Res; 2011 Nov; 17(22):7183-93. PubMed ID: 21976532
[TBL] [Abstract][Full Text] [Related]
9. Epithelial‑mesenchymal transition was identified as a potential marker for breast cancer aggressiveness using reverse transcription‑quantitative polymerase chain reaction.
Andergassen U; Schlenk K; Jeschke U; Sommer H; Kölbl A
Mol Med Rep; 2018 Aug; 18(2):1733-1739. PubMed ID: 29845200
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay.
Markou A; Strati A; Malamos N; Georgoulias V; Lianidou ES
Clin Chem; 2011 Mar; 57(3):421-30. PubMed ID: 21245367
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
[TBL] [Abstract][Full Text] [Related]
13. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
[TBL] [Abstract][Full Text] [Related]
14. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
Corradini P; Voena C; Astolfi M; Delloro S; Pilotti S; Arrigoni G; Bregni M; Pileri A; Gianni AM
Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
[TBL] [Abstract][Full Text] [Related]
15. Low-level expression of HER2 and CK19 in normal peripheral blood mononuclear cells: relevance for detection of circulating tumor cells.
You F; Roberts LA; Kang SP; Nunes RA; Dias C; Iglehart JD; Solomon NA; Friedman PN; Harris LN
J Hematol Oncol; 2008 May; 1():2. PubMed ID: 18577250
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
[TBL] [Abstract][Full Text] [Related]
17. CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.
Tunca B; Egeli U; Cecener G; Tezcan G; Gökgöz S; Tasdelen I; Bayram N; Tolunay S; Umut G; Demirdogen E; Erturk E; Ak S; Cetintas S; Evrensel T
Tumori; 2012; 98(2):243-51. PubMed ID: 22677992
[TBL] [Abstract][Full Text] [Related]
18. Gene profiling and circulating tumor cells as biomarker to prognostic of patients with locoregional breast cancer.
Kuniyoshi RK; Gehrke Fde S; Alves BC; Vilas-Bôas V; Coló AE; Sousa N; Nunes J; Fonseca FL; Del Giglio A
Tumour Biol; 2015 Sep; 36(10):8075-83. PubMed ID: 25976504
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy.
Nunes RA; Li X; Kang SP; Burstein H; Roberts L; Carney W; Blackwell K; Ryan P; Borges V; Iglehart JD; Friedman P; Harris LN
Int J Biol Markers; 2009; 24(1):1-10. PubMed ID: 19404916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
